Rapid Micro Biosystems Inc
NASDAQ:RPID
Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc. is an innovative life sciences technology company. The company is headquartered in Lowell, Massachusetts and currently employs 220 full-time employees. The company went IPO on 2021-07-15. The firm provides automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct platform automates and modernizes the manual microbial quality control (MQC), testing workflows used in pharmaceutical manufacturing operations across the globe. The Growth Direct platform helps on the manufacturing floor, unlocking the power of in-line/at-the-line MQC automation to deliver results with data regulations, and decision making that its customers rely on to ensure the supply of healthcare products. The Company’s Growth Direct platform is the automated MQC solution. The firm offers two consumables plates to capture test samples for analysis on the Growth Direct, which includes an Environmental Monitoring (EM), consumable and a Water/Bioburden (W/BB) consumable.
Rapid Micro Biosystems, Inc. is an innovative life sciences technology company. The company is headquartered in Lowell, Massachusetts and currently employs 220 full-time employees. The company went IPO on 2021-07-15. The firm provides automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct platform automates and modernizes the manual microbial quality control (MQC), testing workflows used in pharmaceutical manufacturing operations across the globe. The Growth Direct platform helps on the manufacturing floor, unlocking the power of in-line/at-the-line MQC automation to deliver results with data regulations, and decision making that its customers rely on to ensure the supply of healthcare products. The Company’s Growth Direct platform is the automated MQC solution. The firm offers two consumables plates to capture test samples for analysis on the Growth Direct, which includes an Environmental Monitoring (EM), consumable and a Water/Bioburden (W/BB) consumable.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
